Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Amy Paller
Northwestern University at Chicago, Department: Dermatology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Exicure
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
This project involves intellectual property that has been licensed to Exicure, a company in which Dr. Paller has equity interests. Exicure’s platform includes nano and siRNA constructs, and Exicure has and is exploring a broad pipeline of SNA-based therapeutics to treat a range of diseases. This research involves testing therapeutics options with respect to the ability of topical GM3S siRNA SNA and topical or oral GZ 161 to promote healing. The close intersection of Exicure interests and this research activity result in a perceived conflict of interest that should be managed.
Glycosphingolipids Mediate Diabetic Wound Healing Impairment
Impaired wound healing in individuals with diabetes remains a major health issue that demands new interventions. We have recently discovered evidence that a glycolipid found on skin cell membranes is increased in diabetic skin and, when depleted in diabetic mice, leads to normal wound healing. Using novel gene suppressive and biochemical interventions to deplete this glycolipid, we will test the reversal of the wound healing defect in diabetic mice and will explore how this glycolipid leads to the poor wound healing of diabetes.
Filed on June 24, 2016.
Tell us what you know about Amy Paller's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Amy Paller filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Amy Paller | Northwestern University at Chicago | Conflict of Interest | AuraSense, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.